Myositis interstitial lung disease and autoantibodies

Shire Chaudhry; Lisa Christopher-Stine

doi:10.3389/fmed.2023.1117071

Frontiers in Medicine (Jun 2023)

Myositis interstitial lung disease and autoantibodies

Shire Chaudhry,
Lisa Christopher-Stine

Affiliations

Shire Chaudhry: Department of Medicine, Luminis Health Anne Arundel Medical Center, Annapolis, MD, United States
Lisa Christopher-Stine: Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, United States

DOI: https://doi.org/10.3389/fmed.2023.1117071
Journal volume & issue: Vol. 10

Abstract

Read online

The aim of this review is to examine and evaluate published literature associated with idiopathic inflammatory myopathies (IIM) and interstitial lung disease (ILD) based on myositis specific autoantibodies (MSA) and the potential clinical significance of each autoantibody subtype for the practicing clinician. The review is a comprehensive search of literature published in PubMed from the year 2005 and onward coinciding with the surge in the discovery of new MSAs. Additionally, we comment on recommended multidisciplinary longitudinal care practices for patients with IIM-ILD with regard to imaging and other testing. Treatment is not covered in this review.

Published in Frontiers in Medicine

ISSN: 2296-858X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Medicine (General)
Website: http://www.frontiersin.org/journals/medicine

About the journal

Abstract

Keywords